chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching heavily; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-May-2021 and was forwarded to Moderna on 14-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching heavily) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PRURITUS (Itching heavily). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 08-Mar-2021, PRURITUS (Itching heavily) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included pain medication.  The patient had visited brentwood health center because of moderna vaccine.   This case was linked to MOD-2021-132198 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up document received on 21-JUL-2021. Outcome of the event was changed to recovered/resolved.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: vertigo; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo) and DIZZINESS (dizziness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VERTIGO (vertigo) and DIZZINESS (dizziness). At the time of the report, VERTIGO (vertigo) and DIZZINESS (dizziness) outcome was unknown.            Concomitant medication information not provided.  Treatment information not provided.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Cough, Dizziness, Feeling abnormal, Mobility decreased
Clinical narrative: exceedingly dizzy and had a a very hazy mind; Was very weak-knees buckling; Stayed in bed and did only essential things and went back to bed; Brain fog; Dry tongue that was sticking to the top of my mouth; nose and cough were minor to nonexistent; sinus infection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (exceedingly dizzy and had a a very hazy mind), ASTHENIA (Was very weak-knees buckling), MOBILITY DECREASED (Stayed in bed and did only essential things and went back to bed), FEELING ABNORMAL (Brain fog) and TONGUE DRY (Dry tongue that was sticking to the top of my mouth) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sinus infection (get these infections every winter), Bronchitis asthmatic, Pneumonia, Vertigo and Seasonal allergy.   On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DIZZINESS (exceedingly dizzy and had a a very hazy mind), ASTHENIA (Was very weak-knees buckling), MOBILITY DECREASED (Stayed in bed and did only essential things and went back to bed), FEELING ABNORMAL (Brain fog), TONGUE DRY (Dry tongue that was sticking to the top of my mouth), COUGH (nose and cough were minor to nonexistent) and SINUSITIS (sinus infection). At the time of the report, DIZZINESS (exceedingly dizzy and had a a very hazy mind), ASTHENIA (Was very weak-knees buckling), MOBILITY DECREASED (Stayed in bed and did only essential things and went back to bed), FEELING ABNORMAL (Brain fog), TONGUE DRY (Dry tongue that was sticking to the top of my mouth), COUGH (nose and cough were minor to nonexistent) and SINUSITIS (sinus infection) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Mar-2021, SARS-CoV-2 test: negative (Negative) negative.         The patient called his PC doctor. Doctor said the patient could have sinus infection as he get these every winters. He put him on antibiotics as corrective treatment. The antibiotics did seem to help, and patient slowly improved. The patient reported this  was not like sinus infection or vertigo patient had had before. It was much different. Patient was just starting to feel better, and in two days out patient was scheduled for his second vaccine on Apr. 2. Patient reported these symptoms lasted for about a month.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Sinusitis, Tongue dry
Clinical narrative: exceedingly dizzy and had a a very hazy mind; Was very weak-knees buckling; Stayed in bed and did only essential things and went back to bed; Brain fog; Dry tongue that was sticking to the top of my mouth; nose and cough were minor to nonexistent; sinus infection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (exceedingly dizzy and had a a very hazy mind), ASTHENIA (Was very weak-knees buckling), MOBILITY DECREASED (Stayed in bed and did only essential things and went back to bed), FEELING ABNORMAL (Brain fog) and TONGUE DRY (Dry tongue that was sticking to the top of my mouth) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sinus infection (get these infections every winter), Bronchitis asthmatic, Pneumonia, Vertigo and Seasonal allergy.   On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DIZZINESS (exceedingly dizzy and had a a very hazy mind), ASTHENIA (Was very weak-knees buckling), MOBILITY DECREASED (Stayed in bed and did only essential things and went back to bed), FEELING ABNORMAL (Brain fog), TONGUE DRY (Dry tongue that was sticking to the top of my mouth), COUGH (nose and cough were minor to nonexistent) and SINUSITIS (sinus infection). At the time of the report, DIZZINESS (exceedingly dizzy and had a a very hazy mind), ASTHENIA (Was very weak-knees buckling), MOBILITY DECREASED (Stayed in bed and did only essential things and went back to bed), FEELING ABNORMAL (Brain fog), TONGUE DRY (Dry tongue that was sticking to the top of my mouth), COUGH (nose and cough were minor to nonexistent) and SINUSITIS (sinus infection) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Mar-2021, SARS-CoV-2 test: negative (Negative) negative.         The patient called his PC doctor. Doctor said the patient could have sinus infection as he get these every winters. He put him on antibiotics as corrective treatment. The antibiotics did seem to help, and patient slowly improved. The patient reported this  was not like sinus infection or vertigo patient had had before. It was much different. Patient was just starting to feel better, and in two days out patient was scheduled for his second vaccine on Apr. 2. Patient reported these symptoms lasted for about a month.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia
Clinical narrative: extremely sore arm / body aches; fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (extremely sore arm / body aches), FATIGUE (fatigue) and CHILLS (chills) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No medical history reported by the reporter.  Concurrent medical conditions included Fibromyalgia (Fatigue and body aches significantly worse) since 1990, GERD since 1980, Paroxysmal atrial tachycardia (P.A.T.) since 1963 and Erosive osteoarthritis since 2000. Concomitant products included FAMOTIDINE (PEPCID AC) for GERD, VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL) for Herpes NOS.    On 06-Feb-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced MYALGIA (extremely sore arm / body aches), FATIGUE (fatigue) and CHILLS (chills). On 07-Feb-2021, MYALGIA (extremely sore arm / body aches), FATIGUE (fatigue) and CHILLS (chills) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered MYALGIA (extremely sore arm / body aches), FATIGUE (fatigue) and CHILLS (chills) to be probably related.    Treatment information was not provided.   This case was linked to MOD-2021-067749 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Follow-up appended on 15-JUL-2021. Patient medical history was added.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm-not bad; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm-not bad) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus. Concomitant products included GLYCYRRHIZA GLABRA, MENTHA PULEGIUM, MORUS NIGRA, OLEA EUROPAEA, TRIGONELLA FOENUM-GRAECUM (ANTI DIABETIC) for Blood sugar increased.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm-not bad). At the time of the report, PAIN IN EXTREMITY (sore arm-not bad) had resolved.            Treatment medications were not provided. He further reported a history of Type 2 Diabetes under good control with a low carb diet and takes oral antidiabetic medication only as needed for elevated blood sugar. Action taken with mRNA-1273 in response to the drug was not applicable.   This case was linked to MOD-2021-139789, MOD-2021-068529 (Patient Link).
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Neutralising antibodies, Pyrexia
Clinical narrative: fever; Body aches; tired; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), MYALGIA (Body aches) and FATIGUE (tired) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Weight loss. Concurrent medical conditions included Relapsing-remitting multiple sclerosis, Energy decreased, Juvenile myoclonic epilepsy, Urinary tract infection NOS, Incontinence and Postmenopausal depression. Concomitant products included RITUXIMAB (RITUXAN), OCRELIZUMAB (OCREVUS), MODAFINIL, LEVETIRACETAM DIHYDROCHLORIDE (KEPPRA [LEVETIRACETAM DIHYDROCHLORIDE]), LAMOTRIGINE, METHENAMINE, TAMSULOSIN, MIRABEGRON (MYRBETRIQ), ESTROGENS CONJUGATED, MEDROXYPROGESTERONE ACETATE (PREMPRO) and ESCITALOPRAM OXALATE for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), MYALGIA (Body aches) and FATIGUE (tired). At the time of the report, PYREXIA (fever), MYALGIA (Body aches) and FATIGUE (tired) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Neutralising antibodies: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Significant follow-up (vaccination date and event outcome)
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy
Clinical narrative: Lethargic; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargic) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy, Pollen allergy, Allergy to animal dander and Hypothyroidism. Concomitant products included LEVOTHYROXINE for an unknown indication.    On 06-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced LETHARGY (Lethargic). On 08-May-2021, LETHARGY (Lethargic) had resolved.            This case was linked to MOD-2021-076470 (Patient Link).
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and PRODUCT DOSE OMISSION ISSUE (missed dose) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Stroke, Seizure and Bone marrow transplant. Concurrent medical conditions included Sickle cell disease NOS. Concomitant products included LAMOTRIGINE (LAMICTAL) and PREGABALIN (LYRICA) for Seizure.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed dose). On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) had resolved and PRODUCT DOSE OMISSION ISSUE (missed dose) outcome was unknown.            Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Patient history updated.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Malaise, Pyrexia, Urinary incontinence
Clinical narrative: Malaise; SOME LOSS OF BLADDER CONTROL; Some loss of balance; FEVER; CHILLS; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Malaise), URINARY INCONTINENCE (SOME LOSS OF BLADDER CONTROL), BALANCE DISORDER (Some loss of balance), PYREXIA (FEVER) and CHILLS (CHILLS) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Malaise), URINARY INCONTINENCE (SOME LOSS OF BLADDER CONTROL), BALANCE DISORDER (Some loss of balance), PYREXIA (FEVER) and CHILLS (CHILLS). At the time of the report, MALAISE (Malaise), URINARY INCONTINENCE (SOME LOSS OF BLADDER CONTROL), BALANCE DISORDER (Some loss of balance), PYREXIA (FEVER) and CHILLS (CHILLS) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information not provided.  Treatment information not provided.
Sex: U
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: mild reaction to moderna dose 1; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (mild reaction to moderna dose 1) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     Concurrent medical conditions included Drug allergy (Polysorbate 80) and Drug allergy (PEG (Polyethylene glycol)).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (mild reaction to moderna dose 1). At the time of the report, HYPERSENSITIVITY (mild reaction to moderna dose 1) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Age: 56.0
Sex: U
Vaccine: COVID19
Symptoms: Antibody test, SARS-CoV-2 antibody test negative
Clinical narrative: no spiked protein noted in lab test; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 ANTIBODY TEST NEGATIVE (no spiked protein noted in lab test) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cancer.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 ANTIBODY TEST NEGATIVE (no spiked protein noted in lab test). At the time of the report, SARS-COV-2 ANTIBODY TEST NEGATIVE (no spiked protein noted in lab test) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: negative (Negative) Negative.         Concomitant medication information not provided.  Treatment information not provided. T-CHOP chemo treatment on 2/26/2021 and patient need to get Cycle 5 on 5/21/2021, so not sure if treatment has something to do with it? treatment   Reporter did not allow further contact
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pustule, Pyrexia
Clinical narrative: red pus filled bumps; fever of 100 degrees; It did wipe me out about 7 hours; This spontaneous case was reported by a consumer and describes the occurrence of PUSTULE (red pus filled bumps), PYREXIA (fever of 100 degrees) and FATIGUE (It did wipe me out about 7 hours) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026C21A and 303B21A) for COVID-19 vaccination.     The patient's past medical history included Thyroid nodule (More nodules discovered on 4/21/21 via ultrasound.) in October 2016, Herpes simplex virus test positive (fewer cold sores) in 1965 and Vasovagal symptoms in 1980. Concurrent medical conditions included Penicillin allergy. Concomitant products included BORAGO OFFICINALIS OIL, FISH OIL, LINUM USITATISSIMUM OIL (OMEGA 3-6-9 [BORAGO OFFICINALIS OIL;FISH OIL;LINUM USITATISSIMUM OIL]) for Heart disorder and Inflammation, TURMERIC [CURCUMA LONGA RHIZOME] and ACHILLEA MILLEFOLIUM, CINNAMOMUM VERUM, HAMAMELIS VIRGINIANA (CINNAMONUM HOMMACORD N) for an unknown indication.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021 at 1:50 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-May-2021, the patient experienced PYREXIA (fever of 100 degrees) and FATIGUE (It did wipe me out about 7 hours). On an unknown date, the patient experienced PUSTULE (red pus filled bumps). On 08-May-2021, PYREXIA (fever of 100 degrees) and FATIGUE (It did wipe me out about 7 hours) had resolved. At the time of the report, PUSTULE (red pus filled bumps) outcome was unknown.            Concomitant medication include Sundown Omega 3-6-9 and used for Heart, Health, Skin. No treatment medication information. The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event was not applicable.   This case was linked to MOD-2021-076646 (Patient Link).
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Headache, Pyrexia
Clinical narrative: Feeling cold; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Feeling cold), HEADACHE (Headache) and PYREXIA (Fever) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No medical history provided. No concomitant medication information provided.     On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced FEELING COLD (Feeling cold), HEADACHE (Headache) and PYREXIA (Fever). The patient was treated with BACILLUS POLYFERMENTICUS (SALVADOL M) at a dose of 250 mg. At the time of the report, FEELING COLD (Feeling cold), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by reporter.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Site Tenderness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Site Tenderness) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SIMVASTATIN for Cholesterol, HCTZ for Hypertension, LEVOTHYROXINE SODIUM (LEVOTHYROXIN) for Hypothyroidism.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE PAIN (Site Tenderness). On 20-Jan-2021, VACCINATION SITE PAIN (Site Tenderness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-030892 (Patient Link).
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: Headache; Body pains; This spontaneous case was reported by a physician and describes the occurrence of HEADACHE (Headache) and MYALGIA (Body pains) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache) and MYALGIA (Body pains). At the time of the report, HEADACHE (Headache) and MYALGIA (Body pains) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment was reported.   This case was linked to MOD-2021-097296 (Patient Link).
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysgeusia, Oligomenorrhoea, Paraesthesia
Clinical narrative: Dizziness; Paraesthesia; Dysgeusia; Extra menstrual cycle; Dizziness; face tingling; tasting metal; This spontaneous case was reported by a non-health professional and describes the occurrence of the first episode of DIZZINESS (Dizziness), PARAESTHESIA (face tingling), DYSGEUSIA (tasting metal), OLIGOMENORRHOEA (Extra menstrual cycle) and the second episode of DIZZINESS (Dizziness) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine since 1995 and Thyroid cancer since 2015. Concomitant products included LEVOTHYROXINE SODIUM (LEVOTHYROXIN) and IBUPROFEN for an unknown indication.    On 12-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced the first episode of DIZZINESS (Dizziness), PARAESTHESIA (face tingling) and DYSGEUSIA (tasting metal). On 25-Apr-2021, the patient experienced OLIGOMENORRHOEA (Extra menstrual cycle). On 12-May-2021, the patient experienced the second episode of DIZZINESS (Dizziness), PARAESTHESIA (Paraesthesia) and DYSGEUSIA (Dysgeusia). On 14-Apr-2021, PARAESTHESIA (face tingling) and DYSGEUSIA (tasting metal) had resolved. On 28-Apr-2021, OLIGOMENORRHOEA (Extra menstrual cycle) had resolved. On 13-May-2021, last episode of DIZZINESS (Dizziness), PARAESTHESIA (Paraesthesia) and DYSGEUSIA (Dysgeusia) had resolved.        This case was linked to US-MODERNATX, INC.-MOD-2021-077893 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077893:Dose 2
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: Still feel awful most days not myself; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Still feel awful most days not myself) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Still feel awful most days not myself). At the time of the report, FEELING ABNORMAL (Still feel awful most days not myself) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Arthritis, Hypoaesthesia, Pain
Clinical narrative: Ache; Arthritis flare up; Numbness in Leg; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Ache), ARTHRITIS (Arthritis flare up) and HYPOAESTHESIA (Numbness in Leg) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ADALIMUMAB (HUMIRA) for Psoriatic arthritis.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Ache), ARTHRITIS (Arthritis flare up) and HYPOAESTHESIA (Numbness in Leg). At the time of the report, PAIN (Ache) outcome was unknown and ARTHRITIS (Arthritis flare up) and HYPOAESTHESIA (Numbness in Leg) had not resolved.            Concomitant Drugs was not Reported. No medical history was provided by the reporter.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Tremor
Clinical narrative: I feel shaky; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (I feel shaky) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00SC21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic.   On 16-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-May-2021, the patient experienced TREMOR (I feel shaky). At the time of the report, TREMOR (I feel shaky) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-May-2021, Blood glucose: 55 (Low) 55.         Concomitant and treatment information not provided. The patient had a lot of crabs on the evening of 16-May-2021. No information regarding corrective treatment was reported by the patient.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow up received which included second dose information  and event outcome was updated
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Feeling hot, Hypoaesthesia, Injection site swelling, Lymphadenopathy
Clinical narrative: hot to the touch; numbness in fingers; tingling in her fingers; her arm pit hurts; arm got swollen at the injection site; lymph nodes are swollen; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING HOT (hot to the touch), HYPOAESTHESIA (numbness in fingers), PARAESTHESIA (tingling in her fingers), AXILLARY PAIN (her arm pit hurts) and INJECTION SITE SWELLING (arm got swollen at the injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced FEELING HOT (hot to the touch), HYPOAESTHESIA (numbness in fingers), PARAESTHESIA (tingling in her fingers), AXILLARY PAIN (her arm pit hurts), INJECTION SITE SWELLING (arm got swollen at the injection site) and LYMPHADENOPATHY (lymph nodes are swollen). At the time of the report, FEELING HOT (hot to the touch), HYPOAESTHESIA (numbness in fingers), PARAESTHESIA (tingling in her fingers), AXILLARY PAIN (her arm pit hurts), INJECTION SITE SWELLING (arm got swollen at the injection site) and LYMPHADENOPATHY (lymph nodes are swollen) outcome was unknown.            Action taken in response to mRNA-1273 was considered to be not applicable.  The patient arm got swollen at the injection site, hot to the touch, and ever since had numbness and tingling in fingers. Concomitant medications were not provided. Treatment information was not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: hot to the touch; numbness in fingers; tingling in her fingers; her arm pit hurts; arm got swollen at the injection site; lymph nodes are swollen; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING HOT (hot to the touch), HYPOAESTHESIA (numbness in fingers), PARAESTHESIA (tingling in her fingers), AXILLARY PAIN (her arm pit hurts) and INJECTION SITE SWELLING (arm got swollen at the injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced FEELING HOT (hot to the touch), HYPOAESTHESIA (numbness in fingers), PARAESTHESIA (tingling in her fingers), AXILLARY PAIN (her arm pit hurts), INJECTION SITE SWELLING (arm got swollen at the injection site) and LYMPHADENOPATHY (lymph nodes are swollen). At the time of the report, FEELING HOT (hot to the touch), HYPOAESTHESIA (numbness in fingers), PARAESTHESIA (tingling in her fingers), AXILLARY PAIN (her arm pit hurts), INJECTION SITE SWELLING (arm got swollen at the injection site) and LYMPHADENOPATHY (lymph nodes are swollen) outcome was unknown.            Action taken in response to mRNA-1273 was considered to be not applicable.  The patient arm got swollen at the injection site, hot to the touch, and ever since had numbness and tingling in fingers. Concomitant medications were not provided. Treatment information was not provided.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Erythema, Hypersensitivity, Nausea, Pyrexia
Clinical narrative: Doctor though was an allergy; rash was moving to the right side of face/nose/cheek/foreheads and in now near left ear; Redness on left side of nose; Nausea; Fever; Dizzy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizzy), HYPERSENSITIVITY (Doctor though was an allergy), ERYTHEMA (Redness on left side of nose), RASH (rash was moving to the right side of face/nose/cheek/foreheads and in now near left ear) and NAUSEA (Nausea) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetic and Solitary kidney.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced DIZZINESS (Dizzy), NAUSEA (Nausea) and PYREXIA (Fever). On 01-May-2021, the patient experienced ERYTHEMA (Redness on left side of nose). On an unknown date, the patient experienced HYPERSENSITIVITY (Doctor though was an allergy) and RASH (rash was moving to the right side of face/nose/cheek/foreheads and in now near left ear). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and LORATADINE (CLARITIN [LORATADINE]) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizzy), HYPERSENSITIVITY (Doctor though was an allergy), ERYTHEMA (Redness on left side of nose), RASH (rash was moving to the right side of face/nose/cheek/foreheads and in now near left ear), NAUSEA (Nausea) and PYREXIA (Fever) outcome was unknown.            No concomitant medications was provided.  For mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular), the reporter did not provide any causality assessments.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Doctor though was an allergy; rash was moving to the right side of face/nose/cheek/foreheads and in now near left ear; Redness on left side of nose; Nausea; Fever; Dizzy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizzy), HYPERSENSITIVITY (Doctor though was an allergy), ERYTHEMA (Redness on left side of nose), RASH (rash was moving to the right side of face/nose/cheek/foreheads and in now near left ear) and NAUSEA (Nausea) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetic and Solitary kidney.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced DIZZINESS (Dizzy), NAUSEA (Nausea) and PYREXIA (Fever). On 01-May-2021, the patient experienced ERYTHEMA (Redness on left side of nose). On an unknown date, the patient experienced HYPERSENSITIVITY (Doctor though was an allergy) and RASH (rash was moving to the right side of face/nose/cheek/foreheads and in now near left ear). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and LORATADINE (CLARITIN [LORATADINE]) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizzy), HYPERSENSITIVITY (Doctor though was an allergy), ERYTHEMA (Redness on left side of nose), RASH (rash was moving to the right side of face/nose/cheek/foreheads and in now near left ear), NAUSEA (Nausea) and PYREXIA (Fever) outcome was unknown.            No concomitant medications was provided.  For mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular), the reporter did not provide any causality assessments.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm only hurt a little; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-May-2021 and was forwarded to Moderna on 18-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm only hurt a little) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm only hurt a little). At the time of the report, PAIN IN EXTREMITY (Arm only hurt a little) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported Treatment medication were not reported   This case was linked to MOD-2021-141281.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Dizziness, Feeling abnormal, Lymphadenopathy, Nausea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VITAMIN B COMPLEX DEFICIENCY (Vitamin B was deficient), DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (Sore throat (same side as injection)), PELVIC PAIN (Pain in her pelvis where tumor had been) and FEELING ABNORMAL (Feels cruddy) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Acute myeloid leukaemia (11 years ago) and Tumor (Tumor in  pelvis). On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (Sore throat (same side as injection)), LYMPHADENOPATHY (Glands are bigger (same side as vaccination)) and NAUSEA (Queasy/Nausea). On 14-May-2021, the patient experienced PELVIC PAIN (Pain in her pelvis where tumor had been). On 18-May-2021, the patient experienced FEELING ABNORMAL (Feels cruddy). On an unknown date, the patient experienced VITAMIN B COMPLEX DEFICIENCY (Vitamin B was deficient). At the time of the report, VITAMIN B COMPLEX DEFICIENCY (Vitamin B was deficient), DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (Sore throat (same side as injection)), PELVIC PAIN (Pain in her pelvis where tumor had been), LYMPHADENOPATHY (Glands are bigger (same side as vaccination)) and NAUSEA (Queasy/Nausea) outcome was unknown and FEELING ABNORMAL (Feels cruddy) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood test: inconclusive (Inconclusive) Vitamin B deficiency. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The concomitant medications were not reported. The treatment information was not provided. This case was linked to MOD-2021-228230. Most recent FOLLOW-UP information incorporated above includes: On 20-Jun-2021: The follow up document was received on 20-JUN-2021.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pelvic pain, Vitamin B complex deficiency
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VITAMIN B COMPLEX DEFICIENCY (Vitamin B was deficient), DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (Sore throat (same side as injection)), PELVIC PAIN (Pain in her pelvis where tumor had been) and FEELING ABNORMAL (Feels cruddy) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Acute myeloid leukaemia (11 years ago) and Tumor (Tumor in  pelvis). On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (Sore throat (same side as injection)), LYMPHADENOPATHY (Glands are bigger (same side as vaccination)) and NAUSEA (Queasy/Nausea). On 14-May-2021, the patient experienced PELVIC PAIN (Pain in her pelvis where tumor had been). On 18-May-2021, the patient experienced FEELING ABNORMAL (Feels cruddy). On an unknown date, the patient experienced VITAMIN B COMPLEX DEFICIENCY (Vitamin B was deficient). At the time of the report, VITAMIN B COMPLEX DEFICIENCY (Vitamin B was deficient), DIZZINESS (Dizziness), OROPHARYNGEAL PAIN (Sore throat (same side as injection)), PELVIC PAIN (Pain in her pelvis where tumor had been), LYMPHADENOPATHY (Glands are bigger (same side as vaccination)) and NAUSEA (Queasy/Nausea) outcome was unknown and FEELING ABNORMAL (Feels cruddy) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood test: inconclusive (Inconclusive) Vitamin B deficiency. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The concomitant medications were not reported. The treatment information was not provided. This case was linked to MOD-2021-228230. Most recent FOLLOW-UP information incorporated above includes: On 20-Jun-2021: The follow up document was received on 20-JUN-2021.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Feeling abnormal, Headache, Heart rate
Clinical narrative: light sensitivity; noises sensitivity,; her head was dazed from noises such as the air conditioner, or other machines; weakness,felt low with energy; headache; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PHOTOPHOBIA (light sensitivity), HYPERACUSIS (noises sensitivity,), FEELING ABNORMAL (her head was dazed from noises such as the air conditioner, or other machines), ASTHENIA (weakness,felt low with energy) and HEADACHE (headache) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer. Concomitant products included TAMOXIFEN for Breast cancer.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced PHOTOPHOBIA (light sensitivity), HYPERACUSIS (noises sensitivity,), FEELING ABNORMAL (her head was dazed from noises such as the air conditioner, or other machines), ASTHENIA (weakness,felt low with energy), HEADACHE (headache) and ARTHRALGIA (joint pain). At the time of the report, PHOTOPHOBIA (light sensitivity), HYPERACUSIS (noises sensitivity,), FEELING ABNORMAL (her head was dazed from noises such as the air conditioner, or other machines), ASTHENIA (weakness,felt low with energy), HEADACHE (headache) and ARTHRALGIA (joint pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Apr-2021, Heart rate: abnormal (abnormal) heart raced a lot, for 30-40 minutes.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication information were not reported
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperacusis, Photophobia
Clinical narrative: light sensitivity; noises sensitivity,; her head was dazed from noises such as the air conditioner, or other machines; weakness,felt low with energy; headache; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PHOTOPHOBIA (light sensitivity), HYPERACUSIS (noises sensitivity,), FEELING ABNORMAL (her head was dazed from noises such as the air conditioner, or other machines), ASTHENIA (weakness,felt low with energy) and HEADACHE (headache) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer. Concomitant products included TAMOXIFEN for Breast cancer.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced PHOTOPHOBIA (light sensitivity), HYPERACUSIS (noises sensitivity,), FEELING ABNORMAL (her head was dazed from noises such as the air conditioner, or other machines), ASTHENIA (weakness,felt low with energy), HEADACHE (headache) and ARTHRALGIA (joint pain). At the time of the report, PHOTOPHOBIA (light sensitivity), HYPERACUSIS (noises sensitivity,), FEELING ABNORMAL (her head was dazed from noises such as the air conditioner, or other machines), ASTHENIA (weakness,felt low with energy), HEADACHE (headache) and ARTHRALGIA (joint pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Apr-2021, Heart rate: abnormal (abnormal) heart raced a lot, for 30-40 minutes.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication information were not reported
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of headache and vaccination site pain in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 001C21A) for COVID-19 immunization. No medical history reported. On Apr 20, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 20, 2021, patient experienced vaccination site pain. On May 17, 2021, patient experienced headache. On Apr 24, 2021, vaccination site pain resolved. At the time of the report, headache outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No treatment medications provided.